C
Carol S. Trempus
Researcher at National Institutes of Health
Publications - 60
Citations - 4554
Carol S. Trempus is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Carcinogenesis & Transgene. The author has an hindex of 25, co-authored 57 publications receiving 4277 citations. Previous affiliations of Carol S. Trempus include Research Triangle Park & Creighton University.
Papers
More filters
Journal ArticleDOI
Capturing and profiling adult hair follicle stem cells
Rebecca J. Morris,Yaping Liu,Lee Marles,Zaixin Yang,Carol S. Trempus,Shulan Li,Jamie S. Lin,Janet A. Sawicki,George Cotsarelis +8 more
TL;DR: It is shown that bulge cells in adult mice generate all epithelial cell types within the intact follicle and hair during normal hair follicle cycling and provide potential targets for the treatment of hair loss and other disorders of skin and hair.
Journal ArticleDOI
Enrichment for living murine keratinocytes from the hair follicle bulge with the cell surface marker CD34.
Carol S. Trempus,Rebecca J. Morris,Carl D. Bortner,George Cotsarelis,Randall S. Faircloth,Jeffrey M. Reece,Raymond W. Tennant +6 more
TL;DR: This work is the first to demonstrate that CD34 is a specific marker of bulge cell keratinocytes in the cutaneous epithelium, potentially providing a tool for the study of carcinogen target cells, gene therapy, and tissue engineering applications.
Journal ArticleDOI
Effects of fixation on RNA extraction and amplification from laser capture microdissected tissue.
TL;DR: Optimal fixation protocols for LCM analysis will facilitate the examination of gene expression in specific cell populations, accelerating investigations of the molecular differences responsible for the phenotypic changes observed during carcinogenesis.
Journal ArticleDOI
Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology
TL;DR: This review summarizes the current knowledge about the generation of hyaluronan fragments of different size and size-dependent differences in hyaluronan signaling as well as their downstream biological effects.
Journal ArticleDOI
Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo
Ana I. Robles,Marcelo L. Rodriguez-Puebla,Adam B. Glick,Carol S. Trempus,Laura A. Hansen,Piotr Sicinski,Raymond W. Tennant,Robert A. Weinberg,Stuart H. Yuspa,Claudio J. Conti +9 more
TL;DR: Evidence that ras-mediated tumorigenesis depends on signaling pathways that act preferentially through cyclin D1 is provided, which results in up to an 80% decrease in the development of squamous tumors generated through either grafting of retroviral ras to keratinocytes, phorbol ester treatment of ras transgenic mice, or two-stage carcinogenesis.